The table below shows ClearPoint Neuro, Inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$23.90M
-$8.95M
-$13.72M
-$16.17M
-$12.70M
-$7.81M
Capital expenditure
$522.00K
$275.00K
$717.00K
$253.00K
$168.00K
$41.00K
Investing cash flow
$615.00K
-$275.00K
$8.95M
-$10.74M
-$168.00K
-$482.00K
Dividends paid
-
-
-
-
CLPT operating cash flow (10-K history)
ClearPoint Neuro, Inc. reported operating cash flow of -$23.90M for fiscal year 2025. That is down 167.0% from -$8.95M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$5.82M (FY 2016) to -$23.90M. Figures come from the company's audited annual reports as filed with the SEC.